Talk to NMC-registered gastroenterologists, Monash-trained dietitians and RCI-licensed psychologists for acidity, gas, bloating, IBS, GERD, constipation, SIBO and IBD — by video, from home. One coordinated plan instead of three providers who never speak.
🎯 Find your match
Instantly matched to the specialist trained for exactly what you're going through. 100% confidential.
Still not sure? Talk to a care coordinator.
👨⚕️ Our gut health experts
Verified · Qualified · Practising · Available online. 30+ gastroenterologists, dietitians and psychologists — NMC-registered or RCI-licensed and background-verified.
Every profile shows qualifications, years in practice and focus areas — you know who you're talking to before you pay.
🏷️ Transparent gut-care pricing
From a first-line GP check to the full 8-Week Gut-Brain Programme — clear prices, no hidden charges.
Quick overview
Most asked question
Yes. Online gastroenterology consultations are legal under the Telemedicine Practice Guidelines, 2020. On HopeQure you choose an NMC-registered gastroenterologist, upload prior reports, and receive a digitally signed prescription and a written gut-care plan.
Conditions managed online include IBS, GERD, SIBO, IBD follow-up, celiac disease, functional dyspepsia and chronic bowel changes. Endoscopy and colonoscopy still need an in-person visit — your specialist tells you whether you actually need one.
📘 Quick guide
A gastroenterologist is a doctor who specialises in the digestive system — the oesophagus, stomach, intestines, liver, gallbladder and pancreas. They diagnose and treat acidity and GERD, IBS, IBD, SIBO, celiac disease, chronic constipation, diarrhoea and fatty liver, and interpret endoscopy, colonoscopy and liver reports.
Online, a gastroenterologist takes a detailed history, reviews your reports, orders only the tests you need, and gives you a digitally signed prescription and a written plan.
Last reviewed October 2026 · Sources listed under Medical references.
Gut Health Conditions · Not All "Gut Issues" Are the Same
"Just bad digestion" is rarely the right diagnosis. Modern gastroenterology distinguishes clinically meaningful phenotypes, each with specific triggers, biomarkers, and treatment pathways. Below are the eight you'll most commonly encounter.
Hard stools >25% of time, straining, incomplete evacuation, abdominal discomfort relieved by bowel movement. Linaclotide, prucalopride, fiber. Low FODMAP responsive.
Loose stools >25% of time, urgency, gas, bloating. Loperamide, rifaximin, eluxadoline, bile acid sequestrants. Low FODMAP highly effective (70% response).
Alternating constipation and diarrhea. Harder to treat — needs individualized dietary + pharmacological approach. Gut-brain therapy particularly beneficial.
Heartburn, regurgitation, chest pain, chronic cough. PPIs first-line (omeprazole, pantoprazole, rabeprazole). H2 blockers alternative. Lifestyle modifications.
Upper abdominal pain, early satiety, postprandial fullness without structural cause. H. pylori testing + eradication. Prokinetics, low-dose tricyclics.
Chronic bloating, excessive gas, abdominal distension within hours of eating. Breath testing (hydrogen/methane). Rifaximin + neomycin treatment. Dietary rotation.
Chronic inflammatory diseases. Bloody diarrhea, weight loss, fatigue, extraintestinal manifestations. 5-ASAs, immunomodulators, biologics (infliximab, adalimumab, vedolizumab, ustekinumab).
Autoimmune reaction to gluten → villous atrophy. Serology (anti-tTG, EMA) + biopsy. Strict gluten-free diet lifelong. Non-celiac gluten sensitivity distinct entity.
Diagnosing which phenotype you have is the single most important decision in gut health care — treatment pathways differ fundamentally. Our gastroenterologists use Rome IV criteria + targeted investigations to make the right diagnosis first time.
🩺 Symptom decoder
A quick reference for common gut symptoms — what they could mean, and what an online gastroenterologist typically evaluates. For vomiting blood or black stools, call 108 immediately.
| Symptom | Likely causes | What a gastroenterologist does |
|---|---|---|
| Burning chest or sour taste after meals | GERD, hiatus hernia, late or large meals, excess weight, H. pylori-related dyspepsia | GERD-Q scoring, meal-timing and trigger review, a time-limited PPI course with a step-down plan, H. pylori testing; endoscopy only if alarm features are present |
| Bloating that builds through the day | IBS, SIBO, FODMAP sensitivity, constipation with retained stool, lactose intolerance | Rome IV assessment, breath testing where indicated, Low FODMAP with a dietitian, constipation check |
| Cramps that ease after a bowel movement | IBS (IBS-C, IBS-D or IBS-M) | Rome IV criteria and IBS-SSS baseline; calprotectin and celiac serology to rule out other disease; antispasmodics, FODMAP and CBT for IBS |
| Loose stools with urgency | IBS-D, bile-acid diarrhoea, celiac disease, lactose intolerance, microscopic colitis, IBD, infection | Stool calprotectin, celiac serology, targeted treatment (for example rifaximin for IBS-D); colonoscopy if red flags |
| Hard stools, straining, infrequent movements | IBS-C, slow transit, pelvic-floor dysfunction, low fibre or fluid, medication side effects, hypothyroidism | Bristol chart review, graded fibre and fluid plan, laxative or secretagogue choice, pelvic-floor referral if needed |
| Gnawing upper-abdominal pain or early fullness | Functional dyspepsia, H. pylori, peptic ulcer, painkiller (NSAID) gastritis, gastroparesis | H. pylori test-and-treat, NSAID review, prokinetic or neuromodulator where indicated; endoscopy if alarm features |
| Symptoms after wheat or rotis | Celiac disease, non-celiac gluten or fructan (FODMAP) sensitivity | Celiac serology (tTG-IgA) before removing gluten, then a dietitian-led plan |
| Avoiding meals out, fear of eating, bathroom anxiety | Gut-related anxiety, gut-brain dysregulation, restrictive eating after long elimination diets | Gut-brain screening, CBT for IBS or gut-directed hypnotherapy, careful food reintroduction |
| 🚨 Blood in stool, black stools, weight loss, night-time symptoms | Alarm features — IBD, bleeding ulcer or colorectal disease must be excluded | Urgent in-person evaluation; call 108 for heavy bleeding or vomiting blood |
Educational only — not a diagnosis. Talk to a verified gastroenterologist
⚠️ GI Alarm Features · When It's Not "Just IBS"
Most gut symptoms are functional (IBS, functional dyspepsia) and benign — but a specific set of "alarm features" demand rapid workup to rule out serious conditions (cancer, IBD, celiac, structural lesions). If you have any of these, do not delay seeing a gastroenterologist.
Fresh blood, dark tarry stools. Rule out: colorectal cancer, IBD, bleeding ulcer, diverticular bleed.
>5% body weight in 6 months without trying. Rule out: malignancy, IBD, malabsorption, celiac disease.
Low hemoglobin + low ferritin. Rule out: occult GI bleeding, celiac disease, colorectal cancer.
Worsening difficulty swallowing, food getting stuck. Rule out: esophageal cancer, achalasia, strictures.
Daily vomiting for weeks, dehydration. Rule out: gastric outlet obstruction, tumor, severe gastroparesis.
Diarrhea or pain waking you from sleep. Functional disorders rarely do this. Rule out: IBD, infection.
Significant bowel habit change in a person over 50 without previous history. Lower threshold for colonoscopy.
First-degree relative with colorectal cancer. Lower screening threshold, earlier colonoscopy.
Lump or mass felt in abdomen. Rule out: malignancy, large IBD mass, hepatomegaly, splenomegaly.
Yellow skin or eyes. Rule out: hepatitis, biliary obstruction, pancreatic cancer, liver disease.
HopeQure is not an emergency service. If you have any of the above, call emergency services or go to the nearest hospital. Our online care is for ongoing gut health management, not acute emergencies.
Common Gut Health Symptoms · Beyond "Bad Digestion"
Gut health symptoms vary enormously by condition. Below are the key symptom categories we assess during consultation. Tracking yours with a symptom diary dramatically improves diagnosis.
Visible or sensation of swelling. Timing (postprandial, cyclical, constant) and triggers (specific foods, menstrual cycle) matter for diagnosis.
Constipation, diarrhea, alternating pattern, urgency, incomplete evacuation. Use Bristol Stool Chart for accurate description.
Burning behind breastbone, sour taste, worse lying flat or after meals. Night-time symptoms indicate more severe GERD.
Location (upper vs lower, specific quadrant), timing, triggers, relief factors. Pain relieved by bowel movement suggests IBS.
Dairy, gluten, FODMAPs, histamine foods. Delayed vs immediate reactions. Non-IgE reactions often missed by standard allergy tests.
Fatigue, brain fog, mood changes, skin issues, joint pain. Gut-brain axis means digestive issues manifest systemically.
Feeling full quickly, loss of appetite, nausea without vomiting. Classic functional dyspepsia pattern or gastroparesis.
Fear of eating out, bathroom proximity anxiety, food avoidance, body hypervigilance. Significantly impacts quality of life.
4 Validated Gut Health Screeners · Baseline + Monitoring
Below are four validated gut health instruments: IBS-SSS (symptom severity), Bristol Stool Chart (stool consistency), GERD-Q (acid reflux severity), and Rome IV IBS Diagnostic Criteria. Your scores are not stored unless you request they be shared with your consulting gastroenterologist.
Francis et al. 1997. Validated measure for IBS symptom severity. Scores: <75 remission · 75-174 mild · 175-299 moderate · ≥300 severe. Repeat quarterly to track treatment response. A 50-point reduction indicates clinically meaningful improvement.
Heaton & Lewis 1997. Validated 7-type visual scale for describing stool consistency. Types 1-2 indicate constipation, 3-5 normal, 6-7 diarrhea. Critical for IBS subtyping and treatment monitoring.
Jones et al. 2009. 6-item validated GERD screening questionnaire. Score ≥8 strongly suggests GERD requiring treatment. Validated for primary care diagnosis and PPI responsiveness prediction.
In the past 7 days, how often did you have:
The international gold standard for diagnosing IBS. Published 2016 Rome Foundation. Positive criteria indicate IBS is likely — but alarm features must be excluded before confirming diagnosis.
Same-day slots with NMC-registered HopeQure gastroenterologists. Bring your IBS-SSS, GERD-Q or Rome IV result — it shortens the history and sharpens the plan.
💻 Simple process
Gastroenterology is unusually history-driven, which is why it works so well by video. Here is exactly what happens at HopeQure.
GP, gastroenterologist, Monash dietitian or psychologist — or let us auto-match you from 30+ specialists by date and language. Same-day slots are common.
Symptoms, Bristol type, medicines (including antacids and painkillers). Upload calprotectin, celiac, H. pylori, endoscopy, colonoscopy or ultrasound reports.
Video, voice or chat. Rome IV-based assessment, report review and an alarm-feature screen in every consultation.
Digital prescription, the tests you actually need (and the ones you don't), diet guidance and clear red-flag advice.
On programmes: WhatsApp support between sessions, a symptom diary reviewed weekly and IBS-SSS re-checks to measure progress.
For decades, gut conditions were a diagnostic wasteland — "it's probably stress", "live with it", "try avoiding spicy food." Modern gastroenterology has transformed completely. Low FODMAP (Monash, 2005+) revolutionized IBS dietary care. Biologic therapy for IBD (ACT-1/2, GEMINI, UNITI) made chronic remission achievable. Rifaximin for IBS-D (TARGET trials). Gut-directed hypnotherapy with 70% response rates. CBT for IBS with Grade A evidence. The gut-brain axis understood scientifically, not dismissed. Modern integrated gut health care achieves outcomes that would have seemed miraculous twenty years ago.
The 8 Pillars of Modern Gut Health Care
Effective gut health care is layered — correct diagnosis, targeted medication, dietary therapy, microbiome support, gut-brain work, trigger identification, advanced therapy when needed, and lifestyle foundations. Modern gastroenterology integrates all eight.
Rome IV criteria application, alarm feature screening, targeted investigations (endoscopy, colonoscopy, breath testing, calprotectin, celiac serology) — correct diagnosis is foundation of everything else.
PPIs for acid suppression, antispasmodics for cramping, prokinetics for motility, laxatives/anti-diarrheals as needed. Right medication, right dose, right duration — not indefinite PPI use.
Monash-protocol Low FODMAP elimination → reintroduction → personalization. Gluten-free for celiac. Specific carbohydrate diets for IBD. Dietitian-supervised to prevent nutritional deficiencies.
Strain-specific probiotics (not generic). Prebiotics for selected conditions. Fermented foods guidance. Faecal microbiota transplant for C. difficile. Judicious antibiotic use.
CBT for IBS (Grade A evidence, 60-70% symptom improvement). Gut-directed hypnotherapy. Mindfulness-based stress reduction. Clinical psychologists trained in gut-brain axis.
Structured food & symptom diary. Elimination-reintroduction protocols. Breath testing for carbohydrate intolerances. Distinguishing true triggers from habitual associations.
For IBD: TNF-inhibitors (infliximab, adalimumab), integrin inhibitors (vedolizumab), IL-23 inhibitors (ustekinumab), JAK inhibitors (tofacitinib, upadacitinib). Infusion coordination.
Sleep regularity (critical for gut motility), exercise (improves transit), stress reactivity work, meal regularity, hydration, caffeine/alcohol modulation. Not optional — foundational.
Integrated Care · Beyond Just Prescriptions
Gut conditions interact with mental health (3-4× anxiety overlap), sleep, hormonal cycles, chronic pain, and nutritional status. HopeQure's integrated model puts your gastroenterologist, dietitian, and clinical psychologist (plus a gynecologist when pregnancy or endometriosis is involved) on one coordinated care record. No fragmented care. No repeating your story. No conflicting advice.
Comorbidities · Gut Health Rarely Travels Alone
Gut conditions have bidirectional relationships with multiple other health domains. The gut-brain axis is just the beginning. Modern gastroenterology addresses these simultaneously rather than in silos.
50-60% of IBS patients have depression; shared serotonin pathways and gut-brain axis. Treating depression often improves IBS symptoms. SSRIs can double-duty.
60-70% of IBS patients have anxiety. Visceral hypersensitivity worsens with anxiety. CBT for IBS specifically addresses this feedback loop.
Poor sleep worsens gut motility, visceral hypersensitivity, and inflammation. Insomnia affects 40% of IBS/IBD patients. Addressing both simultaneously essential.
Avoidant/Restrictive Food Intake Disorder (ARFID) common after prolonged elimination diets. Orthorexia from food fear. Need gentle refeeding alongside gut care.
Fibromyalgia, chronic pelvic pain, interstitial cystitis, migraines all overlap with IBS (central sensitization syndromes). Shared pathophysiology and treatment overlap.
B12, iron, vitamin D, zinc, folate — common in IBD, celiac, chronic diarrhea, long-term PPI use. Must be identified and corrected to improve overall health.
HopeQure's integrated model means your gastroenterologist, dietitian, and psychologist share one coordinated care record — no fragmented care, no repeating your story.
🤝 Support beyond the consultation
Food choices, flare days, reintroduction decisions and medicine questions don't wait for your next slot. This is the support layer around your gut care.
Message your care team for the full 8 weeks of the Gut-Brain Programme, or the full quarter on the Comprehensive plan.
Your digital symptom diary is reviewed weekly on programmes, so patterns are caught early rather than at the next visit.
The step most people skip. Your dietitian runs the reintroduction phase so you end up with a personalised diet, not a permanently restricted one.
CBT for IBS and gut-directed hypnotherapy techniques you practise between sessions — the part of care with the most durable results.
If you've been on antacids for years, a supervised taper plan helps you come off safely — with a clear plan for rebound symptoms.
Gastroenterologist, dietitian and psychologist work from the same notes. Optional ABHA link keeps your records unified. No repeating your story.
📋 Treatment protocols
Rome IV, ACG, AGA and BSG-aligned protocols for the gut conditions we see most. Each is adapted to your age, other conditions and test results.
Goal: A 50-point or greater fall in IBS-SSS — the clinically meaningful threshold
Goal: Symptom control on the lowest effective dose; endoscopy only when alarm features are present
Goal: Steroid-free remission with a normalised calprotectin
Goal: Bloating resolved and relapse risk addressed
Gut Condition vs Recommended Approach Matrix
Below is how modern gastroenterology matches specific approaches to specific conditions. Your gastroenterologist uses this kind of matching in the first consultation.
Food Triggers · What Evidence Actually Shows
Not all "triggers" are equal. Below is how evidence-based gastroenterology ranks common gut triggers by actual research strength and typical response rates.
Individual responses vary. A structured food-symptom diary + dietitian review is the gold standard for identifying YOUR specific triggers — not generic lists.
Medication Deep-Dive · The Full Gut Health Pharmacopoeia
Below are the three major medication families used in modern gastroenterology. Your gastroenterologist tailors to your specific condition, symptom pattern, and comorbidities. We've included real mechanisms, not just brand names, so you can have an informed conversation.
Medications that treat specific gut symptoms as they occur. Choice depends on exact symptom cluster (acid, cramping, motility, nausea). Many are available over the counter — but "OTC doesn't mean indefinite use."
Mechanism: Irreversibly inhibit H+/K+ ATPase in parietal cells, reducing gastric acid production by 90%+. 4.5 taken 30-60 min before breakfast.
Medications: Omeprazole 20-40mg · Pantoprazole 40mg · Rabeprazole 20mg · Esomeprazole 20-40mg · Lansoprazole 30mg.
When to use: GERD symptoms, erosive esophagitis, PPI-responsive dyspepsia, Barrett's esophagus, H. pylori eradication (with antibiotics), peptic ulcer disease, NSAID gastroprotection.
Side effects (long-term use): Vitamin B12 deficiency, magnesium deficiency, osteoporosis/fracture risk, C. difficile infection, community-acquired pneumonia, interstitial nephritis. Rebound acid hypersecretion on discontinuation.
Deprescribing: Should NOT be indefinite without clear ongoing indication. Step down to lowest effective dose or on-demand use. Taper over 4-8 weeks to avoid rebound.
Mechanism: Block histamine H2 receptors on parietal cells, reducing acid production by 60-70%. Faster onset but weaker than PPIs.
Medications: Famotidine 20-40mg · Ranitidine (withdrawn due to NDMA contamination) · Nizatidine · Cimetidine (many drug interactions).
When to use: Mild/intermittent GERD, PRN basis, on-demand before trigger foods, overnight breakthrough acid, PPI tapering bridge. Pregnancy-safer than PPIs.
Side effects: Generally very well tolerated. Headache, dizziness. Tolerance develops with daily use. Cimetidine inhibits CYP enzymes — many drug interactions.
Mechanism: Relax smooth muscle of GI tract via anticholinergic action or direct smooth muscle relaxation.
Medications: Hyoscine (Buscopan) 10mg before meals · Mebeverine 135mg TID · Peppermint oil enteric-coated · Dicyclomine · Alverine citrate.
When to use: IBS cramping pain, functional abdominal pain, before meals that typically trigger symptoms.
Side effects: Dry mouth, blurred vision, constipation, urinary retention (anticholinergic). Peppermint oil can worsen GERD. Avoid in glaucoma, prostate enlargement, intestinal obstruction.
Mechanism: Enhance GI motility through various mechanisms (5-HT4 agonism, dopamine antagonism).
Medications: Prucalopride 1-2mg daily (selective 5-HT4) · Metoclopramide 10mg TID (short-term only due to tardive dyskinesia risk) · Domperidone 10mg TID (QT prolongation concerns) · Itopride.
When to use: Gastroparesis, IBS-C, chronic idiopathic constipation unresponsive to laxatives, functional dyspepsia with delayed emptying.
Side effects: Headache, diarrhea, nausea (prucalopride). Extrapyramidal symptoms, hyperprolactinemia, tardive dyskinesia (metoclopramide — max 12 weeks). QT prolongation (domperidone).
Osmotic laxatives (first-line for constipation): Polyethylene glycol (PEG, Macrogol) 17g daily · Lactulose 15-30mL · Milk of magnesia. Safe for long-term use.
Stimulant laxatives (short-term only): Senna 15-30mg · Bisacodyl 5-10mg. Avoid chronic use (though less harm than previously believed).
Fiber supplements: Psyllium husk 10-20g daily (soluble, works for both constipation and diarrhea) · Methylcellulose · Wheat dextrin.
Anti-diarrheals: Loperamide 2-4mg (max 16mg/day) · Diphenoxylate-atropine · Bile acid sequestrants (cholestyramine) for bile acid diarrhea.
Anti-emetics: Ondansetron 4-8mg (5-HT3 antagonist, can cause constipation) · Metoclopramide · Prochlorperazine · Promethazine.
Beyond symptomatic management, specific IBS pharmacotherapy has evolved significantly. These prescription-only medications target IBS pathophysiology directly and are often more effective than off-label combinations.
Mechanism: Non-absorbable (<0.4%) broad-spectrum antibiotic that modulates gut microbiota without systemic effects. Reduces methane and hydrogen-producing bacteria.
Medications: Rifaximin 550mg TID × 14 days (TARGET-3 regimen for IBS-D) · 400-550mg TID × 10-14 days for SIBO.
Evidence: TARGET-1, TARGET-2, TARGET-3 trials established efficacy. 40-45% of IBS-D patients experience global symptom improvement vs 30% placebo. Benefit lasts weeks to months. Can be repeated.
Side effects: Extremely well tolerated due to minimal absorption. Headache, nausea occasionally. Low risk of C. difficile. No weight gain or systemic antibiotic effects.
Cost consideration: Expensive in India (₹3,000-5,000 per 14-day course). Not always first-line due to cost.
Mechanism: Activates GC-C receptor on intestinal epithelial cells → increases cGMP → increases chloride and bicarbonate secretion → accelerated transit + reduced visceral pain.
Medications: Linaclotide 290mcg daily, 30 min before breakfast · Lower dose 72mcg for chronic constipation.
Evidence: Phase 3 trials showed significant improvement in abdominal pain + bowel movement frequency vs placebo. Response typically within 1-2 weeks.
Side effects: Diarrhea (most common, usually resolves). Avoid in mechanical obstruction. Contraindicated in children <6 years.
Cost consideration: Expensive (₹200-250 per capsule, ₹6,000-7,500/month). Available but prescribed selectively.
Lubiprostone: ClC-2 chloride channel activator. 8-24mcg BID with food. Effective for chronic constipation and IBS-C. Side effect: nausea (improved with food). FDA approved.
Plecanatide: Newer GC-C agonist. 3mg daily. Potentially better tolerability than linaclotide. FDA approved for CIC and IBS-C.
Mechanism: Modulate central and peripheral pain processing, visceral hypersensitivity. Grade A evidence for IBS globally.
Medications: Amitriptyline 10-50mg at bedtime · Nortriptyline 10-50mg · Desipramine 25-100mg · Fluoxetine 20mg · Paroxetine 20-40mg · Mirtazapine 15mg.
When to use: Moderate-severe IBS, functional dyspepsia, when conventional therapy fails. Tricyclics preferred for IBS-D (anticholinergic benefit); SSRIs for IBS-C or when depression comorbid.
Side effects: Sedation, dry mouth, constipation (tricyclics — can be useful in IBS-D). SSRIs: nausea, diarrhea initially, sexual dysfunction. Not addictive at these doses.
Mechanism: μ-opioid agonist + δ-opioid antagonist (locally active in gut). Reduces diarrhea without constipation extremes.
Dose: 100mg BID with food.
Important: Avoid in patients without a gallbladder (pancreatitis risk). Not for severe liver impairment. US-approved; limited availability in India.
Evidence-based strains: Bifidobacterium infantis 35624 (IBS) · Saccharomyces boulardii (antibiotic-associated diarrhea, C. difficile) · Lactobacillus GG (acute diarrhea, pouchitis) · VSL#3 (pouchitis, ulcerative colitis).
Key point: "Probiotics" are not interchangeable. Generic multi-strain probiotics often don't help. Strain-specific use based on condition is critical. Many commercial probiotics have insufficient CFU or wrong strains.
For IBD (Crohn's and Ulcerative Colitis), biologic therapy has transformed outcomes. These prescription medications target specific immune pathways and are prescribed by gastroenterologists specializing in IBD.
Mechanism: Monoclonal antibodies that neutralize tumor necrosis factor alpha, a key cytokine driving IBD inflammation.
Medications: Infliximab (Remicade) IV infusion at weeks 0, 2, 6, then every 8 weeks · Adalimumab (Humira) SC injection every 2 weeks · Golimumab (Simponi) SC monthly (UC only) · Biosimilars widely available at lower cost.
Evidence: ACCENT I/II (Crohn's), ACT-1/2 (UC), SONIC trial (combination with azathioprine superior to monotherapy).
Response rates: 50-60% achieve clinical response. 25-30% achieve mucosal healing. Loss of response over time in 30-40% (immunogenicity).
Side effects: Infection risk (especially TB — screen before starting), lymphoma, demyelinating disease, injection site/infusion reactions, psoriasis paradoxical reactions, hepatitis B reactivation.
Mechanism: Monoclonal antibody against α4β7 integrin, selectively preventing gut-homing of lymphocytes. Gut-selective → fewer systemic infections.
Dose: 300mg IV infusion at weeks 0, 2, 6, then every 8 weeks (or every 4 weeks if sub-optimal response).
Evidence: GEMINI 1 (UC), GEMINI 2 (Crohn's). Slower onset than anti-TNF (12-14 weeks to maximum response) but excellent long-term efficacy and safety.
Advantages: Preferred when prior anti-TNF failure, infection risk, elderly patients, extraintestinal manifestations less common. Lower risk of serious infections.
Mechanism: Monoclonal antibody targeting p40 subunit shared by IL-12 and IL-23 cytokines. Blocks Th1 and Th17 pathways.
Dose: Weight-based IV induction (260-520mg), then 90mg SC every 8 weeks.
Evidence: UNITI 1/2 (Crohn's), UNIFI (UC). Effective in anti-TNF failures. Also used for psoriasis (concurrent benefit).
Side effects: Generally well tolerated. Infection risk lower than anti-TNF. Nasopharyngitis, headache, injection site reactions.
Mechanism: Inhibit Janus kinase enzymes, blocking multiple cytokine signaling pathways.
Medications: Tofacitinib (Xeljanz) 10mg BID induction → 5mg BID maintenance · Upadacitinib (Rinvoq) 45mg daily induction → 15-30mg maintenance · Filgotinib.
Evidence: OCTAVE (UC) for tofacitinib; U-ACHIEVE/U-ACCOMPLISH (UC) and U-EXCEL/U-EXCEED (Crohn's) for upadacitinib.
Side effects: Serious infections, herpes zoster (vaccinate before start), DVT/PE, cardiovascular events, malignancy. Boxed warnings. Rapid oral onset is major advantage.
5-ASA (Mesalamine): First-line for mild-moderate UC. Oral + topical formulations. Pentasa, Asacol, Lialda. Doses up to 4.8g/day.
Corticosteroids: Prednisolone 40-60mg for acute flares. Short-term use only. Budesonide for ileal/right colonic Crohn's. Not for maintenance.
Immunomodulators: Azathioprine 2-2.5mg/kg · 6-mercaptopurine 1-1.5mg/kg · Methotrexate 15-25mg weekly (Crohn's). Steroid-sparing. 3-6 months for full effect.
Antibiotics: Metronidazole, ciprofloxacin for perianal Crohn's, pouchitis, abscess.
IBD Biologic Side Effects & Management · Practical Guide
Modern biologics for IBD transformed disease outcomes but require vigilant monitoring. Below is what we tell every patient starting a biologic.
Different biologics have different onset profiles. Anti-TNF agents often show benefit within 2-6 weeks. Vedolizumab is slower (10-14 weeks to maximum effect). Ustekinumab in between. Combining with azathioprine (SONIC trial) reduces immunogenicity and improves outcomes but increases infection and lymphoma risk — individualized decision. If losing response, drug level monitoring guides optimization vs switching. First biologic often not the last.
Gastroenterologist, Monash-trained dietitian and CBT-for-IBS psychologist on one coordinated plan — the combination most IBS and functional gut patients need.
Gut Health Across Life Stages · Age-Appropriate Care
The gut conditions that peak in your 20s differ from those in your 50s. Below is what each life stage brings — and what to screen for.
Gut issues often first emerge in teen years. School pressures trigger stress-related gut symptoms. IBS onset common. Celiac often diagnosed in this age group.
IBS prevalence peaks. IBD (Crohn's, UC) often first diagnosed. Travel-related GI issues common. Hormonal cyclical patterns emerge in women.
GERD prevalence increases. Hemorrhoids, diverticulosis common. Colonoscopy screening begins. Perimenopausal changes affect gut motility.
New GI symptoms warrant lower threshold for investigation. Multiple medications affect gut. Microbiome diversity declines. Nutritional focus critical.
Gut Health + Pregnancy · Specialized Care
Pregnancy brings unique gut challenges: nausea, GERD, constipation nearly universal. Pre-existing IBD, IBS, celiac need adjusted management. Several standard gut medications are contraindicated in pregnancy. Here's what modern gut-health-informed pregnancy care looks like.
HopeQure coordinates between your gastroenterologist and obstetrician for pregnancy-specific gut health management. Protocol aligned with ACG and ECCO (for IBD) pregnancy guidelines.
Discontinue teratogens: methotrexate (3-6 months before conception), tofacitinib, mycophenolate. Switch to pregnancy-compatible options. IBD should ideally be in remission before conception.
Acid suppression: antacids first, then H2 blockers (famotidine), then PPIs if needed. Loperamide avoid in 1st trimester. Metoclopramide safe. Psyllium fiber safe. Omeprazole widely used.
Methotrexate (contraindicated). Tofacitinib. Mycophenolate. Bismuth. Misoprostol. Castor oil. Chronic high-dose NSAIDs. Many anti-emetics (prochlorperazine, promethazine use caution).
Most biologics (infliximab, adalimumab, vedolizumab) continued through 3rd trimester, held in late 3rd (except Certolizumab). Active disease higher risk than medication. 5-ASA safe. Steroids short-term OK.
Nausea/vomiting (hyperemesis if severe). Reflux (worsens 3rd trimester). Constipation (progesterone + iron). Hemorrhoids. Gallbladder slower. Most self-limiting; lifestyle first.
Breastfeeding compatible: most PPIs, H2 blockers, 5-ASAs, infliximab, adalimumab, vedolizumab, loperamide (short-term). Flare risk postpartum — ensure follow-up.
⚖️ Right specialist for you
Some gut problems are handled perfectly well by a GP. Others need a specialist from day one. Here's how to tell — and when both work together.
4.5 for: a first assessment and straightforward, recent symptoms.
4.5 for: persistent, recurring or complex gut conditions.
The HopeQure approach: both work on one care record. Your GP handles first-line care; your gastroenterologist takes the gut-specific decisions — and the notes travel with you.
Match Your Gut Health Scenario
Answer 4 quick questions. We'll suggest the HopeQure programme tier most likely to help — not every patient needs the most intensive option.
Gut Health Calculators · Practical Tools
These tools help you (and your gastroenterologist) understand the scope of your gut health burden, plan safe FODMAP reintroduction, and taper off long-term PPIs correctly.
Moderate gut health burden. Structured treatment likely to produce significant improvement in your quality of life.
💡 Score >300/month indicates severe burden warranting comprehensive care. Score <100 indicates mild burden suitable for lifestyle + first-line interventions.
After successful Low FODMAP elimination (2-6 weeks), the reintroduction phase systematically tests each FODMAP group to identify YOUR specific triggers. One group per week.
Based on your elimination response, structured reintroduction can begin. Expect 6-8 weeks to identify your personal trigger pattern. Keep a food-symptom diary.
💡 Reintroduction requires dietitian supervision. If symptoms return severely, pause reintroduction and consult. The goal is personalized diet, not permanent restriction.
Long-term PPI use isn't always necessary. This tool estimates whether a supervised deprescribing attempt is appropriate.
Good candidate for structured PPI deprescribing. Start by halving dose for 2 weeks, then alternate days, then on-demand only. H2 blocker bridge available if rebound symptoms.
💡 Barrett's esophagus patients should NOT discontinue PPI without specialist guidance. Rebound symptoms are common in first 2 weeks of taper — persist unless severe.
Transparent Cost Planning · Gut Health Care
Gut health care varies from ₹500/month (simple GERD on generic PPI) to ₹50,000+/month (IBD on biologics). Adjust the sliders to model your care mix.
Includes: 1× dietitian/psychologist ₹1,499/mo
💡 Biologic note: Infliximab/Adalimumab/Vedolizumab/Ustekinumab cost ₹25,000-50,000/month retail in India. Biosimilars significantly cheaper. Insurance often covers under daycare/hospitalization. HopeQure helps with pre-authorization.
💳 EMI available on 8-Week Programme (₹28K) and Comprehensive Plan (₹45K/qtr) through Bajaj Finserv, HDFC, ICICI.
SECOND OPINION SERVICE · ₹1,499
Stuck on PPIs for years without resolution? Told "it's just IBS" without proper workup? Never offered Low FODMAP? Biologic therapy for IBD never discussed? A 45-minute second-opinion consultation reviews your current situation against ACG/AGA 2023-2024 guidelines — and tells you plainly what's working, what's missing, and what modern gastroenterology would look like for your case.
Most common findings: no Low FODMAP ever properly done (just "cut dairy"), chronic PPI without indication, missed H. pylori, missed celiac disease, missed SIBO, IBD on 5-ASA alone when biologic indicated, no behavioural component ever offered, missed food intolerance pattern.
Programme Comparison · Choose the Right Level for You
The 8-Week Gut-Brain Programme is our flagship — most IBS and functional gut condition patients start here. Comprehensive adds coordinated gastro + dietitian + psychologist for complex cases.
All tiers include WhatsApp support · patient portal
Payment · EMI · Insurance
gut health care shouldn't be blocked by upfront costs. Below are the payment options available, from no-cost EMI on programmes to tax deduction under Section 80D to insurance reimbursement pathways.
Split larger programmes into monthly instalments with zero additional cost — available on Comprehensive Plan (₹45,000/quarter) and the 8-Week Gut-Brain Programme (₹28,000).
Most Indian health insurers reimburse doctor consultations, diagnostic tests, and gut-related diagnostic workup — we provide GST invoices and documentation for filing.
gut health treatment expenses (consultations, labs, medications) qualify for tax deduction under Section 80D of the Income Tax Act — up to ₹25,000/year for self, ₹50,000/year for parents.
Many employers now cover doctor consultations under their EAP or wellness benefits — check with your HR. HopeQure has partnerships with 60+ organizations.
Pay by UPI, credit/debit card, net banking, or wallet — instant confirmation, immediate booking. All secure via PCI-DSS certified payment gateway.
PayPal, Stripe, international cards accepted. Video consultations with Indian gut health specialists — from anywhere in the world, at India pricing.
Insurance · OPD Cover · Corporate Programmes
Gut conditions fall under digestive system diseases (ICD-10 K codes) covered by most insurance policies — but coverage varies for specific treatments, especially biologics.
Gut conditions cost Indian employers significantly in absenteeism and reduced productivity. HopeQure runs structured gut health programmes for HR teams. Group screening, tiered pricing, aggregate reporting, virtual delivery. Common in IT, financial services, consulting.
💡 Reimbursement Tip: Common gut health ICD-10 codes: K58 (IBS), K21 (GERD), K50 (Crohn's), K51 (Ulcerative Colitis), K30 (Functional dyspepsia), K90 (Celiac). HopeQure provides ITR-compliant invoices with correct coding + medical necessity letters for biologic pre-authorization.
📞 Insurance Help · Free Callback →Compare Care Options for Gut Health
Where you get gut health care matters enormously. Care quality and outcomes vary dramatically. Here's how HopeQure's integrated model compares.
| Feature | HopeQure Gut Care | Standalone Gastro | GP-Only Care | ER for Flares |
|---|---|---|---|---|
| Gastroenterologist consultation | ✓ Video, ₹1,499 | ✓ In-person | ✗ Referral needed | ~ ER doctor |
| Monash FODMAP-trained dietitian | ✓ On panel | ✗ Rarely | ✗ | ✗ |
| CBT for IBS / gut hypnotherapy | ✓ Trained psychologists | ✗ | ✗ | ✗ |
| Biologic therapy coordination | ✓ Network referrals | ✓ If IBD-focused | ✗ | ✗ |
| Structured symptom diary + review | ✓ Digital | ~ Paper only | ✗ | ✗ |
| Rome IV criteria application | ✓ Standard | ✓ | ~ | ✗ |
| H. pylori test & treat | ✓ Standard protocol | ✓ | ~ | ✗ |
| PPI deprescribing programme | ✓ Structured taper | ~ Variable | ✗ | ✗ |
| Mental health coordination | ✓ Same platform | ✗ Separate | ~ | ✗ |
| Between-visit messaging | ✓ WhatsApp + portal | ✗ | ✗ | ✗ |
| Second opinion service | ✓ Dedicated | ✗ | ✗ | ✗ |
| Starting price | ₹900 GP | ₹1,500-3,500 | ₹300-800 | ₹5,000-20,000 |
| No-cost EMI available | ✓ 3-12 months | ✗ | ✗ | ✗ |
| Video-based | ✓ | ✗ In-person | ~ | ✗ |
ER care is appropriate for acute emergencies (hematemesis, obstruction, perforation) but suboptimal for chronic gut health management.
Long-Term Gut Health Outcomes · What Research Tells Us
Below are the outcome bands evidence-based gut health care makes achievable. Numbers based on landmark trials, Cochrane reviews, and long-term IBD/IBS registries.
Low FODMAP + CBT + optimized medication produces 60-70% symptom improvement in most IBS patients. IBS-SSS reductions of 100+ points typical. Life quality transformation.
Biologic therapy achieves clinical remission in 40-60% of IBD patients. Mucosal healing 25-35%. Dramatic reduction in surgery rates. Long-term disease modification possible.
With proper acid suppression + lifestyle + H. pylori treatment where applicable, 80%+ achieve symptom control. Many successfully step down from daily PPI to on-demand use.
IBS-QOL scores improve 30-50% with structured care. Social functioning restored. Travel confidence returns. Work productivity recovers. The "life planned around toilets" era ends.
CBT for IBS specifically targets food/toilet anxiety. Fear-avoidance patterns reduce 40-60%. Life resumes even before all gut symptoms resolve. Skills last lifetime.
Properly managed, 50-70% of patients on long-term PPIs can step down to lower doses or on-demand use. Reduces long-term risks (B12, bones, infections) significantly.
After FODMAP reintroduction, most patients tolerate 60-80% of originally restricted foods. Permanent restriction uncommon. Social eating possible. Nutritional adequacy maintained.
Correcting gut health improves energy, mood, skin, sleep, cognitive function. The "systemic" symptoms many patients report (brain fog, fatigue) often resolve. Compound benefit.
Realistic Gut Health Milestones · What to Expect When
Gut health transformation takes time. Low FODMAP shows effect in 2-4 weeks. CBT skills build over weeks. Biologics take 10-14 weeks for full effect. Below is what genuinely happens at each milestone with structured gut health care.
Individual trajectories vary based on condition, chronicity, prior treatment history, and adherence. IBD patients have different timelines than IBS patients. What matters is direction (improving vs stable vs worsening), not speed.
Gut Health Myths · What's Actually True
The gut health space is full of misinformation — from "leaky gut" marketing to extreme elimination diets. Here's what the science actually says.
Reality: Generic probiotics have weak evidence for healthy people. Strain-specific use for specific conditions is evidence-based; blanket daily use is not supported. Save your money.
Reality: Only ~1% have celiac disease; 6-13% have non-celiac gluten sensitivity. For the remaining 85-95%, gluten is fine. Unnecessary avoidance causes nutritional deficits and expense.
Reality: Intestinal permeability is real but "leaky gut syndrome" as marketed is not a recognized diagnosis. Expensive "gut healing" supplements rarely have scientific support.
Reality: IBS is a real neurobiological condition with altered gut-brain signaling, visceral hypersensitivity, and microbiome changes. Stress worsens it, doesn't cause it. Real pathophysiology, real treatment.
Reality: Long-term PPI use has real risks: B12/magnesium deficiency, osteoporosis, infections, kidney disease. Not benign. Use shortest effective duration. Taper when possible.
Reality: IgG food sensitivity tests are not clinically validated. They often give false positives, leading to unnecessary elimination. Proper elimination-reintroduction with dietitian is the gold standard.
Reality: Your liver and kidneys handle detoxification. Colon cleanses have no proven benefit, can disrupt the microbiome, and risk complications. Fiber + hydration suffices.
Reality: Many herbal supplements interact with gut medications. Senna long-term causes bowel issues. Even turmeric can cause stomach upset. Discuss supplements with your gastroenterologist.
Got another myth or question?
The Global Reality · Gut Health in Numbers
Below are the global and Indian numbers that frame why systematic, evidence-based gut health care matters so much.
Gut Health Assessment Toolkit · Investigations Modern Gastroenterology Uses
Below are the assessments used across gut health workup and monitoring. Not every patient needs every test — your gastroenterologist tailors the assessment to your presentation. Many conditions can be diagnosed clinically with Rome IV criteria.
| Test / Assessment | Used for | Indicated when | Type | Cost | Reference |
|---|---|---|---|---|---|
| Detailed Gut History(Rome IV screening) | Diagnosis · phenotype identification · alarm feature screening | Every patient | Clinical | Included | Rome IV / ACG |
| 4-Week Symptom Diary(baseline) | Trigger identification · symptom pattern · treatment response tracking | Every patient | Patient log | Free (toolkit) | Standard |
| IBS-SSS Score(symptom severity) | Quantify IBS severity · treatment response monitoring | Baseline + quarterly | Self-report | Free | Francis 1997 |
| Fecal Calprotectin(inflammation) | Distinguishes IBD from IBS. >250 → likely IBD, <50 → likely functional | Any inflammatory features | Stool test | ₹2,500-4,000 | ACG IBS 2021 |
| Celiac Serology(anti-tTG, EMA) | Screen for celiac disease | IBS-D, iron deficiency, family history, atypical symptoms | Blood test | ₹1,500-3,000 | ACG Celiac 2023 |
| H. pylori Testing(breath/stool/biopsy) | Diagnose H. pylori infection | Dyspepsia, ulcers, iron deficiency, family CA stomach | Breath/stool | ₹1,500-3,500 | ACG H. pylori |
| Hydrogen Breath Test(SIBO) | Diagnose SIBO · lactose/fructose intolerance | Chronic bloating, suspected SIBO, carbohydrate intolerance | Breath test | ₹3,500-7,500 | Pimentel 2020 |
| Upper Endoscopy (OGD)(stomach visualization) | Diagnose GERD complications, ulcers, celiac, tumors | Alarm features, refractory GERD, dysphagia, suspected celiac | Procedure | ₹8,000-20,000 | ACG/ASGE |
| Colonoscopy(colon visualization) | Rule out CRC, diagnose IBD, assess bleeding/diarrhea | Alarm features, screening >45, IBD, change in bowel habits | Procedure | ₹8,000-25,000 | USPSTF 2021 |
| Capsule Endoscopy(small bowel) | Visualize small bowel inaccessible to standard scopes | Obscure GI bleeding, suspected small bowel Crohn's | Procedure | ₹30,000-50,000 | AGA 2017 |
| CT/MR Enterography(small bowel imaging) | Assess Crohn's disease extent and complications | Known or suspected Crohn's disease | Imaging | ₹8,000-15,000 | Lamb BSG 2019 |
| Basic Metabolic Panel + CBC(baseline) | Rule out anemia, electrolyte abnormalities, kidney/liver issues | All chronic GI patients | Blood test | ₹800-2,000 | Standard |
| Ferritin + Iron Studies(if anemic) | Diagnose iron deficiency, assess chronicity | Low Hb, chronic GI symptoms | Blood test | ₹600-1,500 | Standard |
| Vitamin B12 + Vitamin D(deficiencies) | Common deficiencies in gut conditions and long-term PPI use | PPI >2 years, celiac, IBD, chronic diarrhea | Blood test | ₹900-2,000 | AGA PPI 2017 |
| Anorectal Manometry(motility) | Diagnose dyssynergic defecation, pelvic floor dysfunction | Refractory constipation, suspected pelvic floor issue | Procedure | ₹5,000-10,000 | Rao 2016 |
| 24-hour pH / Impedance Testing(reflux quantification) | Objective GERD diagnosis when uncertain | PPI non-responders, pre-anti-reflux surgery | Procedure | ₹6,000-12,000 | Katz ACG 2022 |
Landmark Gut Health Studies · Evidence That Shapes Care
Modern gut health care rests on landmark trials that transformed the field. Below are the studies your gastroenterologist references when making treatment decisions.
📱 HopeQure App
Download the HopeQure app to book confidentially, message your care team and keep your gut plan, prescriptions and reports in one place.
Common Questions About Gut Health Care
Our gut-care team is available 7 days a week. Get answers quickly.
Not Ready to Book Yet? Start Here
Not everyone is ready to book a paid consultation on day one. Whether you want a free 15-minute discovery call, you're an NRI needing time-zone-friendly care, or you just want weekly evidence-based tips — these are your low-commitment entry points.
FREE 15-MIN DISCOVERY CALL · NO CARD REQUIRED
Not sure which specialist you need? Wondering which plan fits? Confused by conflicting advice from previous doctors? Book a free 15-minute call with our care coordinator (a trained health educator, not a call-centre agent) — they'll help you understand options, answer questions honestly, and only recommend booking if it makes sense for you.
NRI & INTERNATIONAL PATIENTS
Many Indians living abroad struggle to find gut specialists who understand Indian diets, regional food triggers and Ayurvedic supplement interactions. Our video consultations bridge that gap — with Indian specialists, at India pricing, in your preferred language.
📍 Pan-India coverage
The same NMC-registered gastroenterologists and the same evidence-based protocols — whether you're in a metro, a tier-2 town or abroad.
Medical Review Board · Content Verified by Practicing Gastroenterologists
Every clinical claim, drug dose, and outcome statistic has been reviewed against current ACG, AGA, BSG and ESNM guidelines by practicing gastroenterologists on HopeQure's medical advisory board.
Dr. Arjun Khanna
MD, DM Gastroenterology · IBD Specialist · 16+ years
Content oversight for medical gut health management, IBD biologics, endoscopic procedures
Ms. Kavya Reddy
Monash FODMAP-trained Dietitian · 10+ years in gut health nutrition · Celiac Society India
Dietary therapy content oversight, FODMAP protocols
All content reviewed every 6 months. New landmark trial or guideline update triggers spot-review. No pharmaceutical company sponsorship. No affiliate links. Corrections logged transparently.
📜 View Editorial Policy →Last reviewed: 2026 · Next scheduled review: 2027 · Content lead: Dr. Arjun Khanna · Editorial contact: editorial@hopequre.com
Scientific References · AMA Style
55+ peer-reviewed references underpinning the clinical claims, treatment recommendations, and outcome data. Cross-checked against ACG, AGA, BSG, and ESNM guidelines.
Last updated: 2026 · Reviewed every 6 months by HopeQure Medical Editorial Board.
HopeQure is HIPAA and GDPR aligned, ISO 27001 certified, and follows the highest global standards for medical data confidentiality. gut health records, lab results, imaging files, and consultation notes are treated with the highest sensitivity. Nothing goes to your employer, insurer, family or anyone else without your explicit written consent — per DPDPA 2023 and the Telemedicine Practice Guidelines 2020.
Ready when you are
Connect with a verified NMC-registered gastroenterologist, a Monash-trained dietitian or an RCI-licensed psychologist. Rome IV-based assessment, report review, digital prescription and one coordinated plan. Consultations from ₹900
